Erie Indemnity (ERIE) has drawn fresh attention after recent trading left the stock with a roughly 5.7% gain over the past month and about 13.7% over the past 3 months.
Set against a year-to-date share price return that is down 7% and a 1-year total shareholder return that is down 21.6%, the recent 90-day share price return of 13.7% for Erie Indemnity suggests short term momentum has picked up while longer term performance remains mixed.
Scan how Erie Indemnity compares to other insurers showing fresh price momentum and resilient fundamentals using our curated 79 resilient stocks with low risk scores.
After Erie Indemnity’s recent rebound, the real debate now is whether the bulk of the upside is already reflected in the US$258.37 share price or if the current valuation still leaves meaningful room ahead.
On traditional valuation metrics, Erie Indemnity looks expensive. The stock trades on a P/E of 23.4x against a US Insurance industry average of 11.4x and a peer average of 13.3x, even though the SWS DCF model puts fair value close to the current $258.37 share price at $262.74.
The P/E multiple compares Erie Indemnity’s share price with its earnings per share and is a common way investors assess how much they are paying for each dollar of profit. A higher P/E can imply expectations of stronger or more resilient earnings, a perceived higher quality of earnings, or simply a willingness to pay up for the company’s specific business profile.
For Erie Indemnity, the picture is mixed. The company earns a high 23.4% return on equity and has grown earnings by 18.3% per year over the past 5 years, yet earnings declined 7.7% over the last year and current net profit margins of 14% are below last year’s 15.7%. Against that backdrop, the P/E of 23.4x sits at a clear premium to both the broader US Insurance industry and close peers. This suggests the market is paying a substantial premium multiple for the company’s quality and management profile despite recent profit softness.
Compared with the US Insurance industry average P/E of 11.4x and a peer average of 13.3x, Erie Indemnity’s 23.4x multiple is almost double the sector level and well above more immediate peers. That kind of gap usually reflects a view that the company’s earnings profile, return metrics, or reliability justify a higher price tag, but it also leaves less room for disappointment if results or sentiment weaken.
See what the numbers say about this price — find out in our valuation breakdown.
Result: Price-to-earnings of 23.4x (OVERVALUED)
However, investors also need to weigh risks such as further earnings softness and any shift in sentiment around Erie Indemnity’s premium P/E valuation multiple.
Find out about the key risks to this Erie Indemnity narrative.
While the P/E of 23.4x makes Erie Indemnity look expensive next to the US Insurance industry and peers, the SWS DCF model points to a fair value of $262.74 versus the current $258.37 price. That suggests the stock is trading roughly in line with estimated future cash flows.
For a closer look at how this model works in practice, and what would need to change for the valuation to move materially, Look into how the SWS DCF model arrives at its fair value.
Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Erie Indemnity for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 52 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.
If the mixed signals around Erie Indemnity leave you unsure, move quickly to review the underlying data and stress test your own thesis using the 2 key rewards.
Do not stop with Erie Indemnity. Use this momentum to scan other stocks that may fit your goals, so you are not relying on a single idea.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com